BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Detry O, Govaerts L, Deroover A, Vandermeulen M, Meurisse N, Malenga S, Bletard N, Mbendi C, Lamproye A, Honoré P, Meunier P, Delwaide J, Hustinx R. Prognostic value of 18F-FDG PET/CT in liver transplantation for hepatocarcinoma. World J Gastroenterol 2015; 21(10): 3049-3054 [PMID: 25780305 DOI: 10.3748/wjg.v21.i10.3049]
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/3049.htm
Number Citing Articles
1
Pedro Antonio Cascales-Campos, Pablo Ramírez Romero, Marcel André Schneider, Victor Lopez-Lopez, José Luis Navarro, Laura Frutos, Jose Antonio Pons Miñano, Pascual Parrilla Paricio. Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant?European Journal of Radiology 2017; 91: 155 doi: 10.1016/j.ejrad.2017.03.013
2
Zu-Fei Wang, Xiao-Xi Fan, Min Xu, Min-Jiang Chen, Zhong-Wei Zhao, Jun-Dong Zhou, Jian-Fei Tu, Jing-Jing Song, Xiang-Hua Hu, Chen-Ying Lu, Fa-Zong Wu, Deng-Ke Zhang, Li Chen, Lu Liu, Xi-Hui Ying, Xiao-Fei Xu, Jian-Song Ji. Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using 18F-fluorodeoxyglucose positron emission tomography/computed tomographyTumor Biology 2017; 39(5): 101042831770165 doi: 10.1177/1010428317701656
3
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data SystemJournal of Clinical and Experimental Hepatology 2019; 9(5): 625 doi: 10.1016/j.jceh.2019.07.005
4
Anantha K. Nuthalapati, Steven I. Hanish, Paul J. Thuluvath. Disease Recurrence After Liver Transplantation2016; : 153 doi: 10.1007/978-1-4939-2947-4_11
5
Wei Zhang, Shao-Lv Lai, Jie Chen, Dong Xie, Fei-Xiang Wu, Guan-Qiao Jin, Dan-Ke Su. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrenceWorld Journal of Gastroenterology 2017; 23(35): 6467-6473 doi: 10.3748/wjg.v23.i35.6467
6
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(19): 10271 doi: 10.3390/ijms221910271
7
Xin’ai Wu, Jianbo Li, Cheng Wang, Guojian Zhang, Na Zheng, Xuemei Wang. Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic CarcinomaGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/8763205
8
Willy Liu, Jean Delwaide, Noella Bletard, Philippe Delvenne, Paul Meunier, Roland Hustinx, Olivier Detry. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case reportWorld Journal of Hepatology 2017; 9(11): 562-566 doi: 10.4254/wjh.v9.i11.562
9
Caio de Souza LEVY, Fernando Gomes de Barros COSTA, Daniele de Paula FARIA, Jose Tadeu STEFANO, Bruno COGLIATI, Claudia P OLIVEIRA. 18F-FDG PET/CT AS AN ASSESSMENT TOOL OF HEPATOCELLULAR CARCINOMA SECONDARY TO NON-ALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT IN EXPERIMENTAL MODELArquivos de Gastroenterologia 2019; 56(1): 45 doi: 10.1590/s0004-2803.201900000-02
10
Dong-Wei Xu, Ping Wan, Qiang Xia. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewWorld Journal of Gastroenterology 2016; 22(12): 3325-3334 doi: 10.3748/wjg.v22.i12.3325
11
Pierre Lovinfosse, Roland Hustinx. Nuclear medicine techniques in transplantationClinical and Translational Imaging 2017; 5(1): 45 doi: 10.1007/s40336-016-0216-5
12
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approachesTherapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205
13
Edouard Reizine, Julia Chalaye, Sebastien Mule, Helene Regnault, Clara Perrin, Julien Calderaro, Alexis Laurent, Giuliana Amaddeo, Hicham Kobeiter, Vania Tacher, Emmanuel Itti, Alain Luciani. Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular CarcinomaAmerican Journal of Roentgenology 2021;  doi: 10.2214/AJR.21.26485
14
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging PerspectiveContrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9487938
15
G Dahlqvist, C Moreno, P Starkel, O Detry, L Coubeau, I Jochmans. Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC)Acta Gastro Enterologica Belgica 2021; 84(2): 347 doi: 10.51821/84.2.347
16
Harald Grut, Svein Dueland, Pål Dag Line, Mona Elisabeth Revheim. The prognostic value of 18F–FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastasesEuropean Journal of Nuclear Medicine and Molecular Imaging 2018; 45(2): 218 doi: 10.1007/s00259-017-3843-9
17
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysisAbdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9
18
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
19
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman F. Montasser, Hany Said. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinomaEuropean Radiology 2018; 28(12): 5356 doi: 10.1007/s00330-018-5425-z
20
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
21
Julia Greiser, Wolfgang Weigand, Martin Freesmeyer. Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the LiverPharmaceuticals 2019; 12(3): 137 doi: 10.3390/ph12030137
22
Helena Degroote, Eduard Callebout, Samuele Iesari, Jeroen Dekervel, Jonas Schreiber, Jacques Pirenne, Chris Verslype, Dirk Ysebaert, Peter Michielsen, Valerio Lucidi, Christophe Moreno, Olivier Detry, Jean Delwaide, Roberto Ivan Troisi, Jan Paul Lerut, Hans Van Vlierberghe. Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in BelgiumSurgical Oncology 2020; 33: 231 doi: 10.1016/j.suronc.2019.10.006